I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 22 studies | 27% ± 8% | |
| basal cell | 18 studies | 39% ± 19% | |
| natural killer cell | 14 studies | 20% ± 4% | |
| macrophage | 13 studies | 22% ± 6% | |
| ciliated cell | 12 studies | 32% ± 15% | |
| epithelial cell | 12 studies | 35% ± 15% | |
| fibroblast | 12 studies | 33% ± 16% | |
| club cell | 10 studies | 34% ± 15% | |
| microglial cell | 9 studies | 26% ± 7% | |
| adipocyte | 9 studies | 50% ± 8% | |
| type I pneumocyte | 8 studies | 28% ± 8% | |
| secretory cell | 8 studies | 29% ± 16% | |
| respiratory goblet cell | 7 studies | 34% ± 16% | |
| astrocyte | 7 studies | 28% ± 13% | |
| capillary endothelial cell | 6 studies | 26% ± 12% | |
| CD16-negative, CD56-bright natural killer cell, human | 6 studies | 26% ± 7% | |
| endothelial cell of artery | 5 studies | 22% ± 5% | |
| retinal pigment epithelial cell | 5 studies | 48% ± 11% | |
| hepatocyte | 5 studies | 45% ± 21% | |
| type II pneumocyte | 5 studies | 21% ± 6% | |
| squamous epithelial cell | 4 studies | 44% ± 20% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 20% ± 3% | |
| glomerular endothelial cell | 4 studies | 43% ± 3% | |
| connective tissue cell | 4 studies | 29% ± 6% | |
| retinal cone cell | 4 studies | 28% ± 8% | |
| myeloid cell | 4 studies | 26% ± 9% | |
| endothelial cell of vascular tree | 4 studies | 26% ± 4% | |
| mature NK T cell | 3 studies | 21% ± 3% | |
| renal alpha-intercalated cell | 3 studies | 17% ± 1% | |
| mesothelial cell | 3 studies | 21% ± 1% | |
| glial cell | 3 studies | 28% ± 12% | |
| dendritic cell | 3 studies | 23% ± 5% | |
| abnormal cell | 3 studies | 25% ± 9% | |
| adventitial cell | 3 studies | 29% ± 10% | |
| goblet cell | 3 studies | 27% ± 8% | |
| T cell | 3 studies | 17% ± 1% | |
| podocyte | 3 studies | 47% ± 4% |
